# REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.

> **NCT03285438** · PHASE3 · COMPLETED · sponsor: **University Hospital, Brest** · enrollment: 2774 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** Reduced dose of DOAC
- **DRUG:** Full dose of DOAC

## Key facts

- **NCT ID:** NCT03285438
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-02
- **Primary completion:** 2023-11-08
- **Final completion:** 2023-11-08
- **Target enrollment:** 2774 (ACTUAL)
- **Last updated:** 2023-12-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03285438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03285438, "REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03285438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*